TY  - GEN
AU  - Uffmann,Madita
AU  - Rasche,Mareike
AU  - Zimmermann,Martin
AU  - von Neuhoff,Christine
AU  - Creutzig,Ursula
AU  - Dworzak,Michael
AU  - Scheffers,Lenie
AU  - Hasle,Henrik
AU  - Zwaan,C Michel
AU  - Reinhardt,Dirk
AU  - Klusmann,Jan-Henning
TI  - Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial
SN  - 1528-0020
PY  - 2017///0828
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Child, Preschool
KW  - Chromosomes, Human, Pair 8
KW  - genetics
KW  - Cytarabine
KW  - Cytogenetic Analysis
KW  - Disease-Free Survival
KW  - Down Syndrome
KW  - complications
KW  - Etoposide
KW  - Female
KW  - Humans
KW  - Idarubicin
KW  - Infant
KW  - Leukemia, Myeloid
KW  - Male
KW  - Prospective Studies
KW  - Treatment Outcome
KW  - Trisomy
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2017-01-765057
ER  -